Journal of Shanghai Jiao Tong University (Medical Science) >
Role and research progress of transient receptor potential vanilloid-1 in acute respiratory distress syndrome
Received date: 2024-10-11
Accepted date: 2024-05-20
Online published: 2024-05-28
Supported by
National Natural Science Foundation of China(82272181)
Acute respiratory distress syndrome (ARDS) is a severe critical respiratory disease characterized by refractory hypoxemia, which is caused by intrapulmonary and extrapulmonary factors. It has a rapid onset, and high morbidity and mortality. With the global prevalence and mutation of respiratory viruses, the diagnosis and treatment of ARDS have become more complicated, requiring exploration into the molecular mechanisms and effective therapeutic methods of the occurrence and development of ARDS in clinical practice. Researchers have found that the pathogenesis of ARDS involves the interaction of multiple factors, including imbalances in inflammatory responses and redox reactions, dysregulation of endothelial cells, disruption of alveolar-capillary barrier and abnormalities in coagulation function. Although advancements in molecular biology techniques such as genomics and proteomics have provided new insights into the pathogenesis of ARDS, there is still a lack of early diagnostic biomarker and effective drugs targeted for ARDS. At present, more comprehensive and in-depth basic and clinical research is still needed. Increasing evidence suggests that transient receptor potential vanilloid-1 (TRPV1), also known as the capsaicin receptor, plays a crucial role in respiratory system diseases. TRPV1 is widely distributed in the upper respiratory tract, airway smooth muscle, alveoli and pulmonary blood vessels, participating in mediating airway dilation and constriction, cough reflex, and release of inflammatory mediators related to inflammation and pain, as well as sensing and transmitting various biological signals related to temperature, chemical substances and mechanical stress stimuli in the respiratory system. The widespread distribution and diverse physiological functions of TRPV1 make it a research hotspot in the occurrence and development of respiratory system diseases such as pneumonia, pulmonary edema, cough, asthma and acute lung injury. This article reviews the correlation and molecular mechanisms between ARDS caused by sepsis, traumatic brain injury and respiratory viruses with TRPV1, aiming to summarize the positive effects of regulating TRPV1 expression on the pathogenesis of ARDS and provide reference for strengthening early diagnosis and effective intervention measures for ARDS.
Hong XI , Jie SHEN , Qianzi YANG , Hailei DU , Yan LUO . Role and research progress of transient receptor potential vanilloid-1 in acute respiratory distress syndrome[J]. Journal of Shanghai Jiao Tong University (Medical Science), 2024 , 44(5) : 641 -646 . DOI: 10.3969/j.issn.1674-8115.2024.05.013
| 1 | MATTHAY M A, ARABI Y, ARROLIGA A C, et al. A new global definition of acute respiratory distress syndrome[J]. Am J Respir Crit Care Med, 2024, 209(1): 37-47. |
| 2 | BOS L D J, WARE L B. Acute respiratory distress syndrome: causes, pathophysiology, and phenotypes[J]. Lancet, 2022, 400(10358): 1145-1156. |
| 3 | GROTBERG J C, REYNOLDS D, KRAFT B D. Management of severe acute respiratory distress syndrome: a primer[J]. Crit Care, 2023, 27(1): 289. |
| 4 | ZHANG K H, JULIUS D, CHENG Y F. Structural snapshots of TRPV1 reveal mechanism of polymodal functionality[J]. Cell, 2021, 184(20): 5138-5150.e12. |
| 5 | OZ M, LORKE D E, HOWARTH F C. Transient receptor potential vanilloid 1 (TRPV1)-independent actions of capsaicin on cellular excitability and ion transport[J]. Med Res Rev, 2023, 43(4): 1038-1067. |
| 6 | GORMAN E A, O'KANE C M, MCAULEY D F. Acute respiratory distress syndrome in adults: diagnosis, outcomes, long-term sequelae, and management[J]. Lancet, 2022, 400(10358): 1157-1170. |
| 7 | LIU L, WANG Y, ZHANG Y, et al. Comparison of the Montreux definition with the Berlin definition for neonatal acute respiratory distress syndrome[J]. Eur J Pediatr, 2023, 182(4): 1673-1684. |
| 8 | QADIR N, SAHETYA S, MUNSHI L, et al. An update on management of adult patients with acute respiratory distress syndrome: an official American Thoracic Society Clinical Practice Guideline[J]. Am J Respir Crit Care Med, 2024, 209(1): 24-36. |
| 9 | LU Q Y, YU S F, MENG X Y, et al. MicroRNAs: important regulatory molecules in acute lung injury/acute respiratory distress syndrome[J]. Int J Mol Sci, 2022, 23(10): 5545. |
| 10 | WANG K, RONG G Y, GAO Y X, et al. Fluorous-tagged peptide nanoparticles ameliorate acute lung injury via lysosomal stabilization and inflammation inhibition in pulmonary macrophages[J]. Small, 2022, 18(40): 2203432. |
| 11 | WANG K, WANG M Y, LIAO X M, et al. Locally organised and activated Fth1hi neutrophils aggravate inflammation of acute lung injury in an IL-10-dependent manner[J]. Nat Commun, 2022, 13: 7703. |
| 12 | CAO E H, LIAO M F, CHENG Y F, et al. TRPV1 structures in distinct conformations reveal activation mechanisms[J]. Nature, 2013, 504(7478): 113-118. |
| 13 | 杨维杰, 骆媛, 王永安. 瞬时受体电位通道在呼吸系统疾病中的作用研究进展[J]. 中国药理学与毒理学杂志, 2021, 35(6): 471-480. |
| 13 | YANG W J, LUO Y, WANG Y A. Research progress in role of transient receptor potential channels in respiratory diseases[J]. Chinese Journal of Pharmacology and Toxicology, 2021, 35(6): 471-480. |
| 14 | GAO N, LI M, WANG W M, et al. A bibliometrics analysis and visualization study of TRPV1 channel[J]. Front Pharmacol, 2023, 14: 1076921. |
| 15 | KASHIO M, TOMINAGA M. TRP channels in thermosensation[J]. Curr Opin Neurobiol, 2022, 75: 102591. |
| 16 | ZHAO R, TSANG S Y. Versatile roles of intracellularly located TRPV1 channel[J]. J Cell Physiol, 2017, 232(8): 1957-1965. |
| 17 | BENíTEZ-ANGELES M, MORALES-LáZARO S L, JUáREZ-GONZáLEZ E, et al. TRPV1: structure, endogenous agonists, and mechanisms[J]. Int J Mol Sci, 2020, 21(10): 3421. |
| 18 | ENGLERT J A, BOBBA C, BARON R M. Integrating molecular pathogenesis and clinical translation in sepsis-induced acute respiratory distress syndrome[J]. JCI Insight, 2019, 4(2): e124061. |
| 19 | CAO S, LI H, XIN J, et al. Identification of genetic profile and biomarkers involved in acute respiratory distress syndrome[J]. Intensive Care Med, 2024, 50(1): 46-55. |
| 20 | HU Q, LIU H R, WANG R Y, et al. Capsaicin attenuates LPS-induced acute lung injury by inhibiting inflammation and autophagy through regulation of the TRPV1/AKT pathway[J]. J Inflamm Res, 2024, 17: 153-170. |
| 21 | WANG R, LI Q, WU P, et al. Fe-capsaicin nanozymes attenuate sepsis-induced acute lung injury via NF-κB signaling[J]. Int J Nanomedicine, 2024, 19: 73-90. |
| 22 | JOFFRE J, WONG E, LAWTON S, et al. N-Oleoyl dopamine induces IL-10 via central nervous system TRPV1 and improves endotoxemia and sepsis outcomes[J]. J Neuroinflammation, 2022, 19(1): 118. |
| 23 | ZHANG Q, LUO P, XIA F, et al. Capsaicin ameliorates inflammation in a TRPV1-independent mechanism by inhibiting PKM2-LDHA-mediated Warburg effect in sepsis[J]. Cell Chem Biol, 2022, 29(8): 1248-1259.e6. |
| 24 | LIU Z H, WANG P W, LU S S, et al. Liquiritin, a novel inhibitor of TRPV1 and TRPA1, protects against LPS-induced acute lung injury[J]. Cell Calcium, 2020, 88: 102198. |
| 25 | LIU Q H, ZHANG K, FENG S S, et al. Rosavin alleviates LPS-induced acute lung injure by modulating the TLR-4/NF-κB/MAPK singnaling pathways[J]. Int J Mol Sci, 2024, 25(3): 1875. |
| 26 | ZHOU M, MENG L, HE Q K, et al. Valsartan attenuates LPS-induced ALI by modulating NF-κB and MAPK pathways[J]. Front Pharmacol, 2024, 15: 1321095. |
| 27 | HUANG Q R, LE Y, LI S S, et al. Signaling pathways and potential therapeutic targets in acute respiratory distress syndrome (ARDS)[J]. Respir Res, 2024, 25(1): 30. |
| 28 | KIM J A, WAHLSTER S, LABUZETTA J N, et al. Focused management of patients with severe acute brain injury and ARDS[J]. Chest, 2022, 161(1): 140-151. |
| 29 | BELLANI G, LAFFEY J G, PHAM T, et al. Epidemiology, patterns of care, and mortality for patients with acute respiratory distress syndrome in intensive care units in 50 countries[J]. JAMA, 2016, 315(8): 788-800. |
| 30 | ZIAKA M, EXADAKTYLOS A. Brain-lung interactions and mechanical ventilation in patients with isolated brain injury[J]. Crit Care, 2021, 25(1): 358. |
| 31 | LI C Y, CHEN W L, LIN F, et al. Functional two-way crosstalk between brain and lung: the brain-lung axis[J]. Cell Mol Neurobiol, 2023, 43(3): 991-1003. |
| 32 | MEYFROIDT G, BAGULEY I J, MENON D K. Paroxysmal sympathetic hyperactivity: the storm after acute brain injury[J]. Lancet Neurol, 2017, 16(9): 721-729. |
| 33 | YANG D X, JING Y, LIU Y L, et al. Inhibition of transient receptor potential vanilloid 1 attenuates blood-brain barrier disruption after traumatic brain injury in mice[J]. J Neurotrauma, 2019, 36(8): 1279-1290. |
| 34 | CORRIGAN F, MANDER K A, LEONARD A V, et al. Neurogenic inflammation after traumatic brain injury and its potentiation of classical inflammation[J]. J Neuroinflammation, 2016, 13(1): 264. |
| 35 | PARPAITE T, CARDOUAT G, MAUROUX M, et al. Effect of hypoxia on TRPV1 and TRPV4 channels in rat pulmonary arterial smooth muscle cells[J]. Pflugers Arch, 2016, 468(1): 111-130. |
| 36 | Han DW, Oh JE, Lim BJ, et al. Dexmedetomidine attenuates subarachnoid hemorrhage-induced acute lung injury through regulating autophagy and TLR/NF-κB signaling pathway[J]. Korean J Anesthesiol, 2022, 75(6): 518-529. |
| 37 | MROZEK S, GOBIN J, CONSTANTIN J M, et al. Crosstalk between brain, lung and heart in critical care[J]. Anaesth Crit Care Pain Med, 2020, 39(4): 519-530. |
| 38 | MEZA R C, ANCATéN-GONZáLEZ C, CHIU C Q, et al. Transient receptor potential vanilloid 1 function at central synapses in health and disease[J]. Front Cell Neurosci, 2022, 16: 864828. |
| 39 | CHAI C Z, HO U C, KUO L T. Systemic inflammation after aneurysmal subarachnoid hemorrhage[J]. Int J Mol Sci, 2023, 24(13): 10943. |
| 40 | BARAL P, UMANS B D, LI L, et al. Nociceptor sensory neurons suppress neutrophil and γδ T cell responses in bacterial lung infections and lethal pneumonia[J]. Nat Med, 2018, 24(4): 417-426. |
| 41 | LU W C, YAN J F, WANG C Y, et al. Interorgan communication in neurogenic heterotopic ossification: the role of brain-derived extracellular vesicles[J]. Bone Res, 2024, 12: 11. |
| 42 | ZHANG C N, LI F J, ZHAO Z L, et al. The role of extracellular vesicles in traumatic brain injury-induced acute lung injury[J]. Am J Physiol Lung Cell Mol Physiol, 2021, 321(5): L885-L891. |
| 43 | SHAH R D, WUNDERINK R G. Viral pneumonia and acute respiratory distress syndrome[J]. Clin Chest Med, 2017, 38(1): 113-125. |
| 44 | FAN E, BEITLER J R, BROCHARD L, et al. COVID-19-associated acute respiratory distress syndrome: is a different approach to management warranted?[J]. Lancet Respir Med, 2020, 8(8): 816-821. |
| 45 | LIVIERO F, CAMPISI M, MASON P, et al. Transient receptor potential vanilloid subtype 1: potential role in infection, susceptibility, symptoms and treatment of COVID-19[J]. Front Med, 2021, 8: 753819. |
| 46 | HAUDEBOURG A F, PERIER F, TUFFET S, et al. Respiratory mechanics of COVID-19- versus non-COVID-19-associated acute respiratory distress syndrome[J]. Am J Respir Crit Care Med, 2020, 202(2): 287-290. |
| 47 | THAPA K, VERMA N, SINGH T G, et al. COVID-19-associated acute respiratory distress syndrome (CARDS): mechanistic insights on therapeutic intervention and emerging trends[J]. Int Immunopharmacol, 2021, 101(Pt A): 108328. |
| 48 | SAKATANI H, KONO M, SHIGA T, et al. The roles of transient receptor potential vanilloid 1 and 4 in olfactory regeneration[J]. Lab Investig, 2023, 103(4): 100051. |
| 49 | JAFFAL S M, ABBAS M A. TRP channels in COVID-19 disease: potential targets for prevention and treatment[J]. Chem Biol Interact, 2021, 345: 109567. |
| 50 | HARFORD T J, GROVE L, REZAEE F, et al. RSV infection potentiates TRPV1-mediated calcium transport in bronchial epithelium of asthmatic children[J]. Am J Physiol Lung Cell Mol Physiol, 2021, 320(6): L1074-L1084. |
| 51 | STINSON R J, MORICE A H, SADOFSKY L R. Modulation of transient receptor potential (TRP) channels by plant derived substances used in over-the-counter cough and cold remedies[J]. Respir Res, 2023, 24(1): 45. |
/
| 〈 |
|
〉 |